These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 8428611)

  • 1. Sickle cell vasoocclusion: many issues and some answers.
    Kaul DK; Nagel RL
    Experientia; 1993 Jan; 49(1):5-15. PubMed ID: 8428611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sickle erythrocyte-endothelial interactions in microcirculation: the role of von Willebrand factor and implications for vasoocclusion.
    Kaul DK; Nagel RL; Chen D; Tsai HM
    Blood; 1993 May; 81(9):2429-38. PubMed ID: 8481522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate of deoxygenation modulates rheologic behavior of sickle red blood cells at a given mean corpuscular hemoglobin concentration.
    Kaul DK; Liu XD
    Clin Hemorheol Microcirc; 1999; 21(2):125-35. PubMed ID: 10599596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of endothelial adhesion of sickle cells in vivo: a distinct role for deformable sickle cell discocytes.
    Fabry ME; Fine E; Rajanayagam V; Factor SM; Gore J; Sylla M; Nagel RL
    Blood; 1992 Mar; 79(6):1602-11. PubMed ID: 1547349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEK1/2 inhibitors reverse acute vascular occlusion in mouse models of sickle cell disease.
    Zhao Y; Schwartz EA; Palmer GM; Zennadi R
    FASEB J; 2016 Mar; 30(3):1171-86. PubMed ID: 26631480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathophysiology of sickle cell disease].
    Elion J; Laurance S; Lapouméroulie C
    Med Trop (Mars); 2010 Dec; 70(5-6):454-8. PubMed ID: 21520646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of sickle red cell adhesion and vasoocclusion in the microcirculation by antioxidants.
    Kaul DK; Liu XD; Zhang X; Ma L; Hsia CJ; Nagel RL
    Am J Physiol Heart Circ Physiol; 2006 Jul; 291(1):H167-75. PubMed ID: 16443674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: pathophysiological implications.
    Kaul DK; Fabry ME; Nagel RL
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3356-60. PubMed ID: 2497465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice.
    Belcher JD; Mahaseth H; Welch TE; Vilback AE; Sonbol KM; Kalambur VS; Bowlin PR; Bischof JC; Hebbel RP; Vercellotti GM
    Am J Physiol Heart Circ Physiol; 2005 Jun; 288(6):H2715-25. PubMed ID: 15665055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sickle red cell microrheology and sickle blood rheology.
    Ballas SK; Mohandas N
    Microcirculation; 2004 Mar; 11(2):209-25. PubMed ID: 15280093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo studies of sickle red blood cells.
    Kaul DK; Fabry ME
    Microcirculation; 2004 Mar; 11(2):153-65. PubMed ID: 15280089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous polymerization and adhesion under hypoxia in sickle cell disease.
    Papageorgiou DP; Abidi SZ; Chang HY; Li X; Kato GJ; Karniadakis GE; Suresh S; Dao M
    Proc Natl Acad Sci U S A; 2018 Sep; 115(38):9473-9478. PubMed ID: 30190429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sickle cell vasoocclusion: heterotypic, multicellular aggregations driven by leukocyte adhesion.
    Frenette PS
    Microcirculation; 2004 Mar; 11(2):167-77. PubMed ID: 15280090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheology of sickle cells and its role in microcirculatory dynamics.
    Chien S; Kaperonis AA; King RG; Lipowsky HH; Schmalzer EA; Sung LA; Sung KL; Usami S
    Prog Clin Biol Res; 1987; 240():151-65. PubMed ID: 3615484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2015 Clinical trials update in sickle cell anemia.
    Archer N; Galacteros F; Brugnara C
    Am J Hematol; 2015 Oct; 90(10):934-50. PubMed ID: 26178236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small-molecule cyclic alpha V beta 3 antagonists inhibit sickle red cell adhesion to vascular endothelium and vasoocclusion.
    Finnegan EM; Barabino GA; Liu XD; Chang HY; Jonczyk A; Kaul DK
    Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1038-45. PubMed ID: 17483236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm.
    Turhan A; Weiss LA; Mohandas N; Coller BS; Frenette PS
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3047-51. PubMed ID: 11880644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of pathophysiology and rationale for treatment of sickle cell anemia.
    Rodgers GP
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):2-7. PubMed ID: 9317195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polynitroxyl albumin inhibits inflammation and vasoocclusion in transgenic sickle mice.
    Mahaseth H; Vercellotti GM; Welch TE; Bowlin PR; Sonbol KM; Hsia CJ; Li M; Bischof JC; Hebbel RP; Belcher JD
    J Lab Clin Med; 2005 Apr; 145(4):204-11. PubMed ID: 15962839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise limitation, exercise testing and exercise recommendations in sickle cell anemia.
    Connes P; Machado R; Hue O; Reid H
    Clin Hemorheol Microcirc; 2011; 49(1-4):151-63. PubMed ID: 22214686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.